Rheumatoid Arthritis Research - Treatment, Symptoms, Causes, Medication

Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.


Rheumatoid Arthritis Research Today

Home

View Latest Issue

Information About Rheumatoid Arthritis

Books on Rheumatoid Arthritis

Advertising in Research Today

View Other Research Today Publications



Volume 3 (2006), Issue 2 (February)

  1. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.
    Ann Rheum Dis, 65(3): 394-7. [Abstract] [Full-text]
  2. New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists.
    Ann Rheum Dis, 65(3): 405-7. [Abstract] [Full-text]
  3. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.
    Ann Rheum Dis, 65(3): 285-93. [Abstract] [Full-text]
  4. The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population.
    Ann Rheum Dis, 65(3): 342-7. [Abstract] [Full-text]
  5. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.
    Ann Rheum Dis, 65(3): 316-20. [Abstract] [Full-text]
  6. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
    Ann Rheum Dis, 65(3): 328-34. [Abstract] [Full-text]
  7. Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome.
    Ann Rheum Dis, 65(3): 348-53. [Abstract] [Full-text]
  8. Orthopaedic surgery of the lower limbs in 49,802 rheumatoid arthritis patients: results from the Swedish National Inpatient Registry during 1987 to 2001.
    Ann Rheum Dis, 65(3): 335-41. [Abstract] [Full-text]
  9. Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.
    Ann Rheum Dis, 65(3): 301-5. [Abstract] [Full-text]
  10. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.
    Ann Rheum Dis, 65(3): 366-71. [Abstract] [Full-text]
  11. The CTLA4+49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland.
    Exp Mol Pathol, 80(2): 141-6. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Rheumatoid Arthritis Research Today. All Rights Reserved.



Rheumatoid Arthritis Research Today Archive:

Volume 1 (2004)
  Issue 1 (October)
  Issue 2 (November)
  Issue 3 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)



Rheumatoid Arthritis Books

The Arthritis Breakthrough: NIH Clinical Trials of the New MIRA Therapy: How They Happened; What They Mean To You!

The Arthritis Breakthrough: NIH Clinical Trials of the New MIRA Therapy: How They Happened; What They Mean To You!